Ovid Therapeutics Inc. (OVID)
NASDAQ: OVID · Real-Time Price · USD
1.280
+0.030 (2.40%)
Aug 29, 2025, 4:00 PM - Market closed

Revenue by Product

Fiscal year is January - December.
Fiscal Year
FY 2023FY 2022FY 2021FY 2020
Period Ending
Dec '23 Dec '22 Dec '21 Dec '20
Novel Therapeutics
391.70K
Log In
Log In
Log In
Novel Therapeutics Growth
-73.93%
Log In
Log In
Log In

Revenue by Geography

Fiscal year is January - December.
Fiscal Year
FY 2023FY 2022FY 2021FY 2020
Period Ending
Dec '23 Dec '22 Dec '21 Dec '20
United States
391.70K
Log In
Log In
Log In
United States Growth
-73.93%
Log In
Log In
Log In